DiaSorin SpA (0GZX)

128.70
+3.65(+2.92%)
  • Volume:
    1,704
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    128.70 - 128.70

0GZX Overview

Prev. Close
125.05
Day's Range
128.7-128.7
Revenue
-
Open
124.55
52 wk Range
106.25-208.7
EPS
-
Volume
1,704
Market Cap
6.93B
Dividend (Yield)
1.05
(0.82%)
Average Volume (3m)
14,622
P/E Ratio
21.35
Beta
-
1-Year Change
-16.9%
Shares Outstanding
54,248,257
Next Earnings Date
28 Jul 2022
What is your sentiment on Diasorin?
or
Market is currently closed. Voting is open during market hours.

DiaSorin SpA Company Profile

DiaSorin SpA Company Profile

Employees
3336
Market
Italy

DiaSorin SpA is an Italy-based company engaged in healthcare industry. The Company specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company’s business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. It operates through ELISA immunodiagnostic business portfolio.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuySell
Technical IndicatorsStrong BuyStrong BuyStrong BuyBuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyBuyStrong Sell